Alkermes

Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
Thu, 06/12/14 - 09:33 am
M&A
Merck
Idenix
Achillion
Agios
Alkermes
Celldex Therapeutics
Vertex
Seattle Genetics
Epizyme
The Biggest Biotech Wins of the Week
Motley Fool
Thu, 04/17/14 - 07:46 am
biotech
Puma Biotechnology
aripiprazole lauroxil
Alkermes
neratinib
Roche
Herceptin
bemaciclib
breast cancer
Eli Lilly
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
MannKind
Alkermes
Gilead Sciences
ledipasvir
AbbVie
Afrezza
aripiprazole lauroxil
Pharmacyclics
Imbruvica
This Week in Biotech: The Questcor Buyout and MannKind's Giant Leap to Nowhere
Motley Fool
Sun, 04/13/14 - 10:14 am
Questcor
MannKind
Agios Pharmaceuticals
Mallinckrodt
Alkermes
Merck
Alkermes' schizophrenia drug meets main goal of late-stage study
Yahoo/Reuters
Tue, 04/8/14 - 09:04 am
Alkermes
schizophrenia
aripiprazole lauroxil
Are Biotech Stocks Located in Ireland Top Buyout Candidates?
Wall St 24/7
Wed, 03/19/14 - 11:29 am
Vidara
Shire
Perrigo
M&A
Jazz Pharmaceuticals
Ireland
Endo Health Solutions
biotech
Amarin
Alkermes
Ten Top Biotech Merger and Partnership Candidates
Wall St 24/7
Fri, 03/14/14 - 10:53 am
M&A
biotech
Alkermes
Akorn
Auxilium
Cubist Pharmaceuticals
Hospira
Jazz Pharmaceuticals
Medivation
NPS Pharmaceuticals
Salix
United Therapeutics
4 Tips for Building a Successful Biotech: Richard Pops of Alkermes at #BIOCEO14
BIOtechNOW
Tue, 02/11/14 - 12:02 pm
Alkermes
biotech
BIOCEO2014
Alkermes announces advances with its late-stage CNS pipeline
Yahoo/Fly on the Wall
Wed, 01/8/14 - 08:37 am
Alkermes
aripiprazole lauroxil
schizophrenia
ALKS 5461
major depressive disorder
Alkermes depression drug gets fast track status
Bloomberg/Businessweek
Fri, 10/11/13 - 08:53 am
Alkermes
fast track
ALKS 5461
antidepressants
major depressive disorder
Jazz Seen Next Target Amid Irish Deal Frenzy: Real M&A
Bloomberg
Tue, 08/6/13 - 11:13 am
Jazz Pharmaceuticals
M&A
Alkermes
Earnings Beat at Alkermes
Yahoo/Zacks
Sat, 07/27/13 - 11:18 am
Alkermes
earnings
A Look at Four Major Players in Multiple Sclerosis Treatments
Motley Fool
Wed, 07/24/13 - 12:55 pm
MS
multiple sclerosis
XenoPort
BiogenIdec
Novartis
Alkermes
Tecfidera
Gilenya
ALKS 7106
Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline
TheStreet.com
Thu, 07/18/13 - 09:55 am
Alkermes
multiple sclerosis
MS
monomethyl fumarate
Tecfidera
BiogenIdec
2 Healthcare Companies With Recent Intensive Insider Selling
Seeking Alpha
Thu, 06/13/13 - 10:09 am
insider trading
Alkermes
Pfizer
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
biotech
Alkermes
Celgene
AstraZeneca
Coronado Biosciences
Dendreon
Incyte
Isis Pharmaceuticals
JNJ
Eli Lilly
Merck
Novavax
Novartis
Pfizer
Sangamo BioSciences
Pharmacyclics
Small Companies Are Leading Innovation For New Drugs To Treat Depression
Forbes
Tue, 05/7/13 - 11:31 am
clinical depression
Lundbeck
Alkermes
Novartis
Pfizer
AstraZeneca
Merck
Sanofi
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 04/20/13 - 11:09 am
Vertex Pharmaceuticals
Theravance
Alkermes
Biotech Alkermes Poised To Swell On Pipeline Wins
Investors.com
Wed, 04/17/13 - 10:44 am
Alkermes
Alkermes Announces Restructuring Plan
Yahoo/Zacks
Fri, 04/12/13 - 09:52 am
restructuring
Alkermes

Pages